137 results
8-K
ATOS
Atossa Therapeutics Inc
23 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:00am
(“Nasdaq”) indicating that the Company no longer complies with Nasdaq Listing Rule 5605(b)(1), which requires a board of directors comprised of a majority
DEFA14A
fjg55jwd1ba69w
26 Apr 23
Additional proxy soliciting materials
4:49pm
8-K
EX-3.2
r49bc1re336wb 6q6
26 Apr 23
Amendments to Articles of Incorporation or Bylaws
4:10pm
8-K
s8lqg4kyme0ab uimf9
26 Apr 23
Amendments to Articles of Incorporation or Bylaws
4:10pm
8-K
yxpq6
6 Oct 21
Submission of Matters to a Vote of Security Holders
4:40pm
DEFA14A
3gn94niu5p3u0vz4y
14 Sep 21
Additional proxy soliciting materials
4:12pm
8-K
hwvqupjrji2tng tfx
8 Sep 21
Submission of Matters to a Vote of Security Holders
7:31am